找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Proteomics; From Bench to Bedsid Sayed S. Daoud Book 2008 Humana Press 2008 Bioinformatics.Cancer Research.Carcinom.Oncology.Proteom

[復制鏈接]
查看: 55097|回復: 46
樓主
發(fā)表于 2025-3-21 16:40:52 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Cancer Proteomics
副標題From Bench to Bedsid
編輯Sayed S. Daoud
視頻videohttp://file.papertrans.cn/222/221184/221184.mp4
概述Comprehensive look at the use of proteomic strategies in cancer therapy.Covers all the latest technologies used in proteomics.Includes in-depth information on the human proteome and the role of the FD
叢書名稱Cancer Drug Discovery and Development
圖書封面Titlebook: Cancer Proteomics; From Bench to Bedsid Sayed S. Daoud Book 2008 Humana Press 2008 Bioinformatics.Cancer Research.Carcinom.Oncology.Proteom
描述.This book provides the reader with broad perspectives and breadth of knowledge on current topics related to the use of proteomic strategies in cancer therapy as well as anticipated challenges that may arise from its application in daily practice. The book is divided into 4 parts. The first part begins with the current technologies used in proteomics that allow for protein profiling and for the identification of druggable targets in human samples. Mass spectrometry based protein characterization and protein microarrays hold great promise of predicting response to specific drugs in cancer therapy. The second part deals with the use proteomics in cell signaling. At the present, the pharmaceutical and biotechnology industries have many potentially useful small molecule inhibitors of many pathways important in cancer that have yet to be taken to clinical trials. Understanding protein-protein interaction and posttranslational modifications through proteomics will likely make it much more feasible to do effective clinical trials of these small molecules alone and in combinations to overcome drug resistance and improve patient care. The third part of the book moves from signaling to actua
出版日期Book 2008
關鍵詞Bioinformatics; Cancer Research; Carcinom; Oncology; Proteomics; Translation; classification; diagnostics; p
版次1
doihttps://doi.org/10.1007/978-1-59745-169-7
isbn_softcover978-1-61737-807-2
isbn_ebook978-1-59745-169-7Series ISSN 2196-9906 Series E-ISSN 2196-9914
issn_series 2196-9906
copyrightHumana Press 2008
The information of publication is updating

書目名稱Cancer Proteomics影響因子(影響力)




書目名稱Cancer Proteomics影響因子(影響力)學科排名




書目名稱Cancer Proteomics網絡公開度




書目名稱Cancer Proteomics網絡公開度學科排名




書目名稱Cancer Proteomics被引頻次




書目名稱Cancer Proteomics被引頻次學科排名




書目名稱Cancer Proteomics年度引用




書目名稱Cancer Proteomics年度引用學科排名




書目名稱Cancer Proteomics讀者反饋




書目名稱Cancer Proteomics讀者反饋學科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 21:39:10 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:58:51 | 只看該作者
Cancer Proteomics978-1-59745-169-7Series ISSN 2196-9906 Series E-ISSN 2196-9914
地板
發(fā)表于 2025-3-22 07:38:31 | 只看該作者
PSED II and the Kauffman Firm SurveyThis chapter describes the key elements in tumor biomarker development toward clinical use. In particular, it focuses on the analytical aspects of assay development and how to implement new tumor biomarkers in the clinical setting.
5#
發(fā)表于 2025-3-22 09:06:59 | 只看該作者
6#
發(fā)表于 2025-3-22 16:57:29 | 只看該作者
https://doi.org/10.1007/978-1-59745-169-7Bioinformatics; Cancer Research; Carcinom; Oncology; Proteomics; Translation; classification; diagnostics; p
7#
發(fā)表于 2025-3-22 20:00:45 | 只看該作者
New Feminist Perspectives on Embodiment merited the Nobel Prize were especially revolutionary examples, but mass analyzer design, ion chemistry, ion detection, and data analysis have all seen significant performance advances. In the area of proteomics, the key moment for any of these innovations and advances comes when they are transferr
8#
發(fā)表于 2025-3-22 23:02:48 | 只看該作者
9#
發(fā)表于 2025-3-23 05:14:59 | 只看該作者
https://doi.org/10.1007/978-1-349-22450-0ions, prediction of clinical outcome and monitoring response to cancer treatments. The exciting move toward kinase-targeted therapy has brought new technical challenges in profiling protein kinase genes and proteins as surrogate clinical biomarkers, particularly in light of clinical data correlating
10#
發(fā)表于 2025-3-23 07:58:50 | 只看該作者
New Findings in Long-Wave Research individual. Numerous proteomic technologies are available, and selected ones relevant to development of personalized therapy are described. Cancer biomarkers discovered by proteomics can be used for diagnosis as well as drug targets, thus facilitating the integration of diagnostics and therapeutics
 關于派博傳思  派博傳思旗下網站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網 吾愛論文網 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經驗總結 SCIENCEGARD IMPACTFACTOR 派博系數 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網安備110108008328) GMT+8, 2025-10-19 22:53
Copyright © 2001-2015 派博傳思   京公網安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
汾西县| 德钦县| 延津县| 新宁县| 岳西县| 墨竹工卡县| 自治县| 怀仁县| 柳州市| 柞水县| 拜城县| 大石桥市| 许昌县| 海盐县| 乾安县| 牡丹江市| 开鲁县| 乌苏市| 开封县| 凌海市| 申扎县| 抚顺市| 岫岩| 蒙阴县| 五原县| 沁阳市| 大港区| 潍坊市| 黄陵县| 清水河县| 鄢陵县| 沂南县| 全椒县| 庆云县| 佛冈县| 革吉县| 耿马| 和平区| 宁化县| 五大连池市| 获嘉县|